Hennion & Walsh Asset Management’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Sell |
51,822
-2,394
| -4% | -$57.2K | 0.05% | 440 |
|
|
2025
Q1 | $1.35M | Sell |
54,216
-2,169
| -4% | -$53.9K | 0.06% | 394 |
|
|
2024
Q4 | $1.06M | Buy |
56,385
+8,636
| +18% | +$163K | 0.05% | 455 |
|
|
2024
Q3 | $719K | Buy |
47,749
+12,299
| +35% | +$185K | 0.03% | 530 |
|
|
2024
Q2 | $1.01M | Buy |
+35,450
| New | +$1.01M | 0.05% | 417 |
|
|
2021
Q4 | – | Sell |
-22,606
| Closed | -$1.27M | – | 778 |
|
|
2021
Q3 | $1.27M | Sell |
22,606
-3,640
| -14% | -$204K | 0.07% | 310 |
|
|
2021
Q2 | $1.59M | Buy |
26,246
+61
| +0.2% | +$3.7K | 0.08% | 274 |
|
|
2021
Q1 | $1.84M | Buy |
+26,185
| New | +$1.84M | 0.11% | 247 |
|